
Annual report 2026
added 03-17-2026
HealthEquity Net Debt 2011-2026 | HQY
Net Debt can be roughly defined as financial liabilities that an entity classifies in the financing section together with the resources available to service those financial liabilities[1]
Net debt is the obligations that remain after deducting all assets and other liabilities from a company or individual. It represents the sum of debts that an organization or person must repay to their creditors or other parties.
Net debt can include various types of obligations such as loans, borrowings, lease liabilities, or credit card payments. It is important to note that net debt does not include current expenses or obligations such as payroll expenses or current bills.
Assessing net debt is an important financial indicator for evaluating the financial position of a company or individual. If net debt significantly exceeds assets, it may indicate financial difficulties and insolvency. In such cases, the company or individual may face difficulties in meeting their obligations and managing their finances.
Net debt can also be used to compare the financial stability of different companies. The lower the net debt relative to assets, the more stable and financially sound they are considered.
Overall, understanding net debt helps evaluate the financial soundness and ability of a company to meet their obligations. It is an important indicator that assists in making decisions about lending, investments, and financial management.
Annual Net Debt HealthEquity
| 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 648 M | 770 M | 480 M | 664 M | 709 M | 688 M | 1.03 B | -361 M | -199 M | -140 M | -83.6 M | -111 M | -13.9 M | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 1.03 B | -361 M | 314 M |
References
- Pizzo, M., Moscariello, N., & Vinciguerra, R. (2015). Market Incentives and Regulators' Activity Shaping Financial Information: An Analysis of the Net Debt Disclosure in Italy. International Journal of Business and Management, 10(1), 1.
Net Debt of other stocks in the Health information services industry
| Issuer | Net Debt | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Accolade
ACCD
|
-12 M | - | 0.29 % | $ 206 M | ||
|
Change Healthcare
CHNG
|
4.65 B | - | - | $ 9.03 B | ||
|
Cerner Corporation
CERN
|
720 M | - | - | $ 27.9 B | ||
|
HealthStream
HSTM
|
-39.3 M | $ 21.2 | 1.1 % | $ 644 M | ||
|
American Well Corporation
AMWL
|
-178 M | $ 5.7 | -1.04 % | $ 91.5 M | ||
|
Computer Programs and Systems
CPSI
|
193 M | - | 4.4 % | $ 133 M | ||
|
Covetrus
CVET
|
863 M | - | - | $ 2.94 B | ||
|
iCAD
ICAD
|
-16.8 M | - | - | $ 102 M | ||
|
Castlight Health, Inc.
CSLT
|
-34.4 M | - | -7.28 % | $ 227 M | ||
|
HMS Holdings Corp.
HMSY
|
67.9 M | - | - | $ 3.29 B | ||
|
Inovalon Holdings, Inc.
INOV
|
763 M | - | - | $ 6.37 B | ||
|
NextGen Healthcare
NXGN
|
-42.1 M | - | - | $ 1.6 B | ||
|
1Life Healthcare
ONEM
|
-41.2 M | - | - | $ 3.37 B | ||
|
Premier
PINC
|
128 M | - | - | $ 2.33 B | ||
|
Omnicell
OMCL
|
-327 M | $ 34.99 | 1.54 % | $ 1.61 B | ||
|
Phreesia
PHR
|
-84 M | $ 11.25 | -0.27 % | $ 614 M | ||
|
OptimizeRx Corporation
OPRX
|
20.6 M | $ 7.25 | 6.93 % | $ 124 M | ||
|
Evolent Health
EVH
|
232 M | $ 2.27 | 0.67 % | $ 213 M | ||
|
Schrödinger
SDGR
|
-121 M | $ 11.48 | -0.78 % | $ 843 M | ||
|
MTBC
MTBC
|
-1.02 M | - | -0.58 % | $ 51.7 M | ||
|
Teladoc Health
TDOC
|
225 M | $ 5.59 | 3.04 % | $ 985 M | ||
|
GoodRx Holdings
GDRX
|
44 M | $ 2.07 | 1.23 % | $ 798 M | ||
|
Signify Health
SGFY
|
-126 M | - | -0.02 % | $ 7.21 B | ||
|
SCWorx Corp.
WORX
|
-376 K | $ 0.13 | 2.6 % | $ 190 K | ||
|
R1 RCM
RCM
|
638 M | - | - | $ 3.81 B | ||
|
Akerna Corp.
KERN
|
13.7 M | - | - | $ 161 M | ||
|
Allscripts Healthcare Solutions
MDRX
|
181 M | - | -10.39 % | $ 886 M | ||
|
Health Catalyst
HCAT
|
105 M | $ 1.1 | 0.46 % | $ 76.9 M | ||
|
NantHealth
NH
|
4.4 M | - | -46.64 % | $ 10.4 M | ||
|
10x Genomics
TXG
|
-264 M | $ 20.82 | 5.07 % | $ 2.44 B | ||
|
Streamline Health Solutions
STRM
|
2.4 M | - | - | $ 21.4 M | ||
|
Tabula Rasa HealthCare
TRHC
|
-54.5 M | - | - | $ 255 M | ||
|
Progyny
PGNY
|
-143 M | $ 17.76 | -1.63 % | $ 1.52 B | ||
|
So-Young International
SY
|
-563 M | $ 3.16 | 8.59 % | $ 251 M | ||
|
Veeva Systems
VEEV
|
-1.33 B | $ 178.3 | -0.45 % | $ 29.2 B |